HTA17 Cost-Effectiveness Analysis of Tocilizumab for The Treatment of COVID-19 in Hospitalised Patients on Corticosteroids, From the Italian NHS Perspective
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1477
https://www.valueinhealthjournal.com/article/S1098-3015(22)03682-8/fulltext
Title :
HTA17 Cost-Effectiveness Analysis of Tocilizumab for The Treatment of COVID-19 in Hospitalised Patients on Corticosteroids, From the Italian NHS Perspective
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03682-8&doi=10.1016/j.jval.2022.09.1477
First page :
Section Title :
Open access? :
No
Section Order :
11020